Icon ADS News (NASDAQ:ICLR)

Latest Icon ADS News Headlines
DateTimeSource
Headline
11/20/20067:00AMPRNUSICON plc Selects TrackWise for Audit and Corrective and Preventive Action Management
Cites Flexibility and Industry Experience as Reasons for Selection HOLMDEL, N.J., Nov. 20 /PRNewswire/ -- Sparta Systems, Inc. (Sparta), the maker of TrackWise(R) and the market leader in enterprise Quality Management System (QMS) software for the life sciences industries, today announced that ICON plc (NASDAQ:ICLR... More...>>
05/12/200612:00PMPRNUSICON plc (ICLR) Executive Chairman to Ring The NASDAQ Stock Market Closing Bell
Company Celebrates Anniversary NEW YORK, May 12 /PRNewswire-FirstCall/ -- The following is being issued by NASDAQ (NASDAQ:NDAQ): What: Dr. John Climax, Executive Chairman of ICON plc (NASDAQ:ICLR) will preside over the closing bell to celebrate ICON's 8 year listing anniversary on the NASDAQ. Where: NASDAQ... More...>>
02/28/200510:00AMPRNUSMedidata Solutions & Icon Clinical Research Formalize Global Partnership
Medidata Solutions & Icon Clinical Research Formalize Global Partnership 4th Largest Global Clinical CRO brings Medidata's electronic Clinical Data Management solution in-house to deliver clinical trial implementation services NEW YORK, Feb. 28 /PRNewswire/ -- Medidata Solutions, a global electronic clinical data management... More...>>
07/06/200412:02PMPRNUSICON and Beacon Bioscience Partner for Medical Imaging
ICON and Beacon Bioscience Partner for Medical Imaging DUBLIN, Ireland and DOYLESTOWN, Pa., July 6 /PRNewswire/ -- ICON plc (NASDAQ:ICLR), a global clinical research organization and Beacon Bioscience, Inc., the Medical Imaging CRO, announced today that ICON has acquired a majority interest and invested new equity in... More...>>
06/14/20048:57AMPRNUSIntegic Teams With ICON Clinical Research to Develop End-to-End Clinical Trials Management System
Integic Teams With ICON Clinical Research to Develop End-to-End Clinical Trials Management System Combination of Skills Leads to Unique, Quicker-to-Market Solution CHANTILLY, Va., June 14 /PRNewswire/ -- Integic Corporation, a leading provider of software applications and business process management solutions, today... More...>>
05/05/200411:38AMPRNUSRanbaxy Appoints Dr. Kathleen A. Spreen as Medical Director
Ranbaxy Appoints Dr. Kathleen A. Spreen as Medical Director PRINCETON, N.J., May 5 /PRNewswire/ -- Ranbaxy USA Inc., (RUSA), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), has selected Kathleen A. Spreen, DO, MS, MPH, to be Executive Director of Medical and Clinical Affairs. Dr. Spreen comes to Ranbaxy... More...>>
04/01/20045:00AMPRNUSICON gibt starkes drittes Quartal des Geschäftsjahres 2004 bekannt; Betriebsergebnis verbessert sich um 42%, Gewinn pro Aktie b
ICON gibt starkes drittes Quartal des Geschäftsjahres 2004 bekannt; Betriebsergebnis verbessert sich um 42%, Gewinn pro Aktie beträgt US$ 0,47 DUBLIN, Irland, April 1 /PRNewswire/ -- - Highlights - Drittes Quartal des Geschäftsjahrs 2004 - Nettoumsatzerlös im dritten Quartal stieg im Vergleich zum... More...>>
04/01/20045:00AMPRNUSICON Reports Another Strong Quarter With a 42% Increase in Operating Income and EPS of $0.47 for the Third Quarter FY 2004
ICON Reports Another Strong Quarter With a 42% Increase in Operating Income and EPS of $0.47 for the Third Quarter FY 2004 DUBLIN, Ireland, April 1 /PRNewswire-FirstCall/ -- - Highlights - Third Quarter Fiscal 2004 * Third quarter net revenues increased 30% over the third quarter of fiscal 2003 to $76.9 million and... More...>>
04/01/20045:00AMPRNUSICON Reports Another Strong Quarter with a 42% Increase in Operating Income and EPS of US$0.47 for the Third Quarter FY 2004
ICON Reports Another Strong Quarter with a 42% Increase in Operating Income and EPS of US$0.47 for the Third Quarter FY 2004 DUBLIN, Ireland, April 1 /PRNewswire/ -- - Highlights - Third Quarter Fiscal 2004 - Third quarter net revenues increased 30% over the third quarter of fiscal 2003 to $76.9 million... More...>>
04/01/20045:00AMPRNUSICON annonce des résultats très positifs pour le trimestre - Hausse de 42% du bénéfice d'exploitation et BPA de USD 0,47 pou
ICON annonce des résultats très positifs pour le trimestre - Hausse de 42% du bénéfice d'exploitation et BPA de USD 0,47 pour le troisième trimester de l'exercice 2004 DUBLIN, Irlande, April 1 /PRNewswire/ -- - Points saillants du troisième trimestre fiscal 2004 - Au troisième trimestre de l'exercice... More...>>
04/01/20045:00AMPRNUSICON registra otro cuarto fuerte con un aumento de ingresos operativos del 42% y una ganancia por acción de 0,47 dólares duran
ICON registra otro cuarto fuerte con un aumento de ingresos operativos del 42% y una ganancia por acción de 0,47 dólares durante el tercer cuarto del año fiscal 2004 DUBLÍN, Irlanda, April 1 /PRNewswire/ -- - Punto de interés - Tercer cuarto fiscal de 2004 - Los ingresos netos del tercer cuarto han aumentado... More...>>


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
34 site:2us nasdaq iclr080720 06:47 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )